Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial.

Pieber T., Bode B., Mertens A., Cho Y., Christiansen E., Hertz C., ...More

The lancet. Diabetes & endocrinology, vol.7, pp.528-539, 2019 (SCI-Expanded)

• Publication Type: Article / Article
• Volume: 7
• Publication Date: 2019
• Doi Number: 10.1016/s2213-8587(19)30194-9
• Journal Name: The lancet. Diabetes & endocrinology
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Page Numbers: pp.528-539
• Marmara University Affiliated: Yes